Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 23914207)

1.
2.
3.

Plasma malondialdehyde levels and risk factors for the development of chronic complications in type 2 diabetic patients on insulin therapy.

Kaefer M, De Carvalho JA, Piva SJ, da Silva DB, Becker AM, Sangoi MB, Almeida TC, Hermes CL, Coelho AC, Tonello R, Moreira AP, Garcia SC, Moretto MB, Moresco RN.

Clin Lab. 2012;58(9-10):973-8.

PMID:
23163113
4.

Plasma lipid peroxidation and totalantioxidant status among dyslipidaemic and hypertensive Nigerians with high risk of coronary heart disease.

Ogunro PS, Balogun WO, Fadero FF, Idogun ES, Oninla SO, Elemile PO, Eziyi AK.

West Afr J Med. 2009 Mar;28(2):87-91.

PMID:
19761169
5.
6.
7.

Oxidative stress in families of type 1 diabetic patients.

Matteucci E, Giampietro O.

Diabetes Care. 2000 Aug;23(8):1182-6.

8.

Atherogenic lipoprotein profile in families with and without history of early myocardial infarction.

Dobiásová M, Raslová K, Rauchová H, Vohnout B, Ptácková K, Frohlich J.

Physiol Res. 2001;50(1):1-8.

9.

The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.

Toth PP, Simko RJ, Palli SR, Koselleck D, Quimbo RA, Cziraky MJ.

Cardiovasc Diabetol. 2012 Sep 14;11:109. doi: 10.1186/1475-2840-11-109.

10.

Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia.

Guérin M, Le Goff W, Lassel TS, Van Tol A, Steiner G, Chapman MJ.

Arterioscler Thromb Vasc Biol. 2001 Feb;21(2):282-8.

11.
12.

Significance of alterations in plasma lipid profile levels in breast cancer.

Franky Dhaval Shah, Shilin Nandubhai Shukla, Pankaj Manubhai Shah, Patel HR, Prabhudas Shankerbhai Patel.

Integr Cancer Ther. 2008 Mar;7(1):33-41. doi: 10.1177/1534735407313883.

PMID:
18292593
13.

Diabetic dyslipidemia.

Kreisberg RA.

Am J Cardiol. 1998 Dec 17;82(12A):67U-73U; discussion 85U-86U. Review.

PMID:
9915665
14.
15.

Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia.

Bayhan G, Koçyigit Y, Atamer A, Atamer Y, Akkus Z.

Gynecol Endocrinol. 2005 Jul;21(1):1-6.

PMID:
16048794
16.

Study of changes in antioxidant enzymes status in diabetic post menopausal group of women suffering from cardiovascular complications.

Kumawat M, Sharma TK, Singh N, Ghalaut VS, Vardey SK, Sinha M, Kaushik GG.

Clin Lab. 2012;58(3-4):203-7.

PMID:
22582492
17.

Lipid profile and its relation to fasting insulin level in non-insulin dependent diabetes mellitus (NIDDM).

Uddin F, Miah AK.

Bangladesh Med Res Counc Bull. 1995 Aug;21(2):64-72.

PMID:
8815864
19.

Fenofibrate: a review of its lipid-modifying effects in dyslipidemia and its vascular effects in type 2 diabetes mellitus.

Keating GM.

Am J Cardiovasc Drugs. 2011 Aug 1;11(4):227-47. doi: 10.2165/11207690-000000000-00000. Review.

PMID:
21675801
20.

Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications.

Kesavulu MM, Giri R, Kameswara Rao B, Apparao C.

Diabetes Metab. 2000 Nov;26(5):387-92.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk